by;Dr. Ari Weitzner
For over 60 years, cataracts has been treated in China with eye drops containing the non-prescription drug pirenoxine.
Researchers recently tested the potential effectiveness of pirenoxine as a treatment for cataracts by investigating whether and how pirenoxine interacts with selenite or calcium ions, which have been proven as factors leading to the formation of lens cataracts.
As reported in the journal Inorganic Chemistry, researchers found that pirenoxine reduced the cloudiness of the lens solution containing calcium by 38 per cent and reduced the cloudiness of the selenite solution by 11 per cent.
Researchers concluded that the results may provide a rationale for using pirenoxine as an anti-cataract agent and advocated further biological studies.
Subscribe to:
Post Comments (Atom)
1 comment:
The only research done was on a very small group of people and was done by the company that sells the drops. And I think its cheap way to Treat of Cataract.
Post a Comment